HIGHLIGHT
Rybelsus

Rybelsus Description

semaglutide

Manufacturer:

Novo Nordisk

Distributor:

Zuellig Pharma

Marketer:

Novo Nordisk
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Description
Rybelsus 3 mg tablets: Each tablet contains 3 mg semaglutide*.
Rybelsus 7 mg tablets: Each tablet contains 7 mg semaglutide*.
Rybelsus 14 mg tablets: Each tablet contains 14 mg semaglutide*.
*human glucagon-like peptide-1 (GLP-1) analogue produced in Saccharomyces cerevisiae cells by recombinant DNA technology.
Excipient with known effect: Each tablet, regardless of semaglutide strength, contains 23 mg sodium.
Excipients/Inactive Ingredients: Salcaprozate sodium, Povidone K90, Microcrystalline cellulose, Magnesium stearate.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in